HOUSTON--(BUSINESS WIRE)--Saranas, Inc. announced today that it has reached the midpoint for enrollment in SAFE-MCS, a multi-center, single arm, open-label clinical trial evaluating the safety of ...
HOUSTON--(BUSINESS WIRE)--Saranas, Inc. announced today that over 1,200 patients have been treated with the Early Bird ® Bleed Monitoring System, the first and only FDA-approved bleed detection system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results